ConductScience.org, home
ANGPTL3: angiopoietin like 3
API referenceFor AI assistants

Gene · 27329

Papers2,231

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

121 to 140 of 2,231

Download this page as JSON
TitleJournalYearPMIDFound bySource
Nucleic Acid-Based Therapies - The Next Frontier in Treating Dyslipidemias.Can J Cardiol202641581757PubTator, text miningPubMed
Novel Cerebrovascular Disease Blood Biomarkers Identified by Targeted Proteomics in a High-Risk Native American Population.World Neurosurg202641581656PubTator, text miningPubMed
Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH Registry.JACC Adv202641579830PubTator, text miningPubMed
The ANGPTL3-integrin α5 axis drives retinal vascular leakage in diabetic retinopathy.J Transl Med202641555340PubTator, text miningPubMed
The liver as a metabolic and immune hub in Alzheimer's disease: From mechanisms to therapeutic opportunities.J Prev Alzheimers Dis202641529520PubTator, text miningPubMed
Targeted delivery of genome editors in vivo.Nat Biotechnol202641526513PubTator, text miningPubMed
Evaluation of Pathogenic Variants Associated With Monogenic Disorders of Dyslipidemia in Patients With Well Characterised MASLD.Liver Int202641514510PubTator, text miningPubMed
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials.Drugs202641501311PubTator, text miningPubMed
In vivo gene editing for lipid management: An early perspective from ANGPTL3-targeted CRISPR-Cas9 therapy.Mol Ther202641485467PubTator, text miningPubMed
Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies.Curr Cardiol Rep202641483441PubTator, text miningPubMed
Atherogenic dyslipidaemia and residual cardiovascular risk: Understanding the link to heart disease.Eur J Clin Invest202641482986PubTator, text miningPubMed
Does siRNA therapy against ANGPTL3 bring new hope in homozygous familial hypercholesterolaemia?Lancet Diabetes Endocrinol202641422813PubTator, text miningPubMed
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial.Lancet Diabetes Endocrinol202641422812PubTator, text miningPubMed
Inhibition of angiopoietin-like protein 3 as a target for managing hypertriglyceridemia.Curr Opin Endocrinol Diabetes Obes202641405255PubTator, text miningPubMed
Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia.JACC Case Rep202641369603PubTator, text miningPubMed
The role of ANGPTL8 in metabolism and cardiovascular diseases: Consensus and controversy.Atherosclerosis202641274199PubTator, text miningPubMed
ANGPTL3 promotes colorectal carcinoma progression and metastasis through regulating COL1A2 transcription via interacting with integrin αVβ3.Cancer Lett202641260514PubTator, text miningPubMed
Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromes.Curr Opin Endocrinol Diabetes Obes202641208140PubTator, text miningPubMed
Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease.Gene Ther202641152563PubTator, text miningPubMed
Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report.J Atheroscler Thromb202641062288PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/27329/papers?page=7

API referenceFor AI assistants